Press release
August 26, 2026
Odyssey Therapeutics to Participate in Upcoming Investor Conferences
Odyssey Therapeutics, Inc. (ODTX)
BOSTON, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Odyssey Therapeutics, Inc. (Nasdaq: ODTX) (“Odyssey” or the “Company”), a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing medicines that